[Skip to Content]
[Skip to Content Landing]
November 13, 1954


Author Affiliations

451 Clarkson Ave. Brooklyn 3, N. Y.

JAMA. 1954;156(11):1106. doi:10.1001/jama.1954.02950110068029

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  Some time ago, at the annual meeting of the American Urological Association, I participated in a program concerned with the use of antibiotics in urology. One of the participants was Dr. John K. Lattimer, who discussed the treatment of tuberculous infections of the kidney. His paper was based on clinical investigative work undertaken at the Bronx Veterans Administration Hospital, a participant in the over-all VA program that deals with the chemotherapy of tuberculosis. Dr. Lattimer's paper was one of the best presentations I have ever heard on the subject of the natural history, the treatment, and the current prognosis of renal tuberculosis. His careful studies, which could only have been undertaken in an institution such as a large VA hospital in which adequate follow-up studies could be made over a period of years, indicate that while formerly, with no specific treatment, the case fatality rate in renal

First Page Preview View Large
First page PDF preview
First page PDF preview